Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT03692429
What this trial is testing

AlloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells

Who this might be right for
Unresectable Metastatic Colorectal Cancer
Celyad Oncology SA 49
Testing effectiveness (Phase 2)UnknownNCT00750126
What this trial is testing

Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Solid TumorsHematologic Neoplasms
University Hospital, Clermont-Ferrand 30
Large-scale testing (Phase 3)Study completedNCT01503515
What this trial is testing

Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant

Who this might be right for
Fungal InfectionHematopoietic and Lymphoid Cell Neoplasm
Children's Oncology Group 292
Testing effectiveness (Phase 2)UnknownNCT04593368
What this trial is testing

Fecal Microbiome Transplantation (FMT) in Pediatric Patients Colonized With Antibiotic-resistant Pathogens Before Hematopoietic Stem Cell Transplantation (HSCT)

Who this might be right for
Antibiotic Resistant Strain
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT03663933
What this trial is testing

Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation

Who this might be right for
Lymphoproliferative DisordersAutoimmune LymphoproliferativePrimary T-cell Immunodeficiency Disorders+2 more
National Cancer Institute (NCI) 71
Not applicableStudy completedNCT04469985
What this trial is testing

Allogeneic Stem Cell Transplantation (ALLO-SCT) in Elderly: 17-years Retrospective GITMO Survey

Who this might be right for
Allogeneic Stem Cell Transplantation in Elderly Patients
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 2,061
Not applicableUnknownNCT00563108
What this trial is testing

Basiliximab for the Treatment of Acute Graft-versus-host Disease After Allogeneic Stem Cell Transplantation

Who this might be right for
Graft vs Host DiseaseHematopoietic Stem Cell Transplantation
Hospital Authority, Hong Kong 60
Testing effectiveness (Phase 2)Ended earlyNCT04205240
What this trial is testing

Reduce Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed Multiple Myeloma

Who this might be right for
Recurrent Plasma Cell Myeloma
Srinivas Devarakonda 1
Testing effectiveness (Phase 2)Ended earlyNCT00053014
What this trial is testing

S0125, Chemotherapy, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Older Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
SWOG Cancer Research Network 5
Testing effectiveness (Phase 2)Study completedNCT01283776
What this trial is testing

Cyclophosphamide as Sole Graft-Versus-Host-Prophylaxis After Allogeneic Stem Cell Transplantation

Who this might be right for
Multiple MyelomaNon-Hodgkin-LymphomaHodgkin's Disease
University of Cologne 11
Testing effectiveness (Phase 2)Study completedNCT00002547
What this trial is testing

Chemotherapy and Bone Marrow Transplantation in Treating Patients Acute Myeloid With Leukemia or Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Barbara Ann Karmanos Cancer Institute 280
Not applicableNot Yet RecruitingNCT07034755
What this trial is testing

Phase II Clinical Study on the Safety and Efficacy of Combined CAR-T Therapy Following Autologous Stem Cell Transplantation in Multiple Myeloma

Who this might be right for
Multiple Myeloma (MM)Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)Chimeric Antigen Receptor T-cell
The Affiliated Hospital of Xuzhou Medical University 20
Early research (Phase 1)Study completedNCT00673868
What this trial is testing

Cytomegalovirus (CMV) Specific Cytotoxic T Lymphocytes (CTL) When Used for Prophylaxis Against CMV in Recipients of Allogeneic, T Cell Depleted Stem Cell Transplants

Who this might be right for
Cytomegalovirus Infections
Milton S. Hershey Medical Center 2
Testing effectiveness (Phase 2)Study completedNCT03339297
What this trial is testing

An Open-Label Study of Defibrotide for the Prevention of Acute Graft-versus-Host-Disease (AGvHD)

Who this might be right for
Graft-versus-host DiseaseAcute-graft-versus-host Disease
Jazz Pharmaceuticals 152
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07638332
What this trial is testing

Evaluation of the Safety and Efficacy of LB-DTK-BKV in Patients With BK Virus-Associated Hemorrhagic Cystitis Following Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Hemorrhagic Cystitis
LucasBio 42
Not applicableStudy completedNCT06837987
What this trial is testing

Modified Transplantation Regimen and aGVHD Prophylaxis for Severe Aplastic Anemia in the Setting of Allogeneic HSCT.

Who this might be right for
Aplastic AnaemiaTransplantation Conditioning
Hematology department of the 920th hospital 72
Very early researchUnknownNCT04889963
What this trial is testing

Regeneration of Posterior Cruciate Ligament Injury Using Hypoxic Conditioned Allogenic Adipose Mesenchymal Stem Cell and Condition Medium

Who this might be right for
Adypose Mesenchimal Stem CellLigament RuptureLigament Derived Conditined Medium
Gadjah Mada University 16
Very early researchActive Not RecruitingNCT07144384
What this trial is testing

Intratumoral Injection of Standard Universal Donor Expanded Natural Killer Cells and TGF-beta Imprinted Natural Killer Cells for the Treatment of Skin Squamous Cell Carcinoma and Basal Cell Carcinoma

Who this might be right for
Skin Basal Cell CarcinomaSkin Nodular Basal Cell CarcinomaSkin Squamous Cell Carcinoma
Ohio State University Comprehensive Cancer Center 4
Testing effectiveness (Phase 2)Study completedNCT02037204
What this trial is testing

IMPACT: Safety and Feasibility of a Single-stage Procedure for Focal Cartilage Lesions of the Knee.

Who this might be right for
Foreign-Body ReactionInflammationEffusion (L) Knee+1 more
UMC Utrecht 35
Testing effectiveness (Phase 2)Study completedNCT02651376
What this trial is testing

Safety and Efficacy of Allogenic Adoptive Immune Therapy for Advanced AIDS Patients

Who this might be right for
Human Immunodeficiency VirusImmunodeficiency
Beijing 302 Hospital 20
Next Page